SCIENCE & APPROACH

Beyond Genomics

Targeting Core Lineage Biology

Cancer cells are sustained by core lineage programs—deeply embedded biological pathways that establish and preserve cell identity. In healthy tissue, these programs tightly regulate development and function. In cancer, they are co-opted and reinforced, becoming fundamental drivers of tumor growth, survival, and therapeutic resistance.

Rather than being incidental features of malignancy, these lineage programs create hardwired dependencies that tumors rely on to thrive. Because they operate at the foundation of cellular identity, they represent powerful but historically difficult therapeutic opportunities.

At CORE Biomedicine, we leverage cutting-edge biology to uncover these essential dependencies and translate them into druggable targets. By integrating deep biological insight with precision drug discovery, we aim to develop medicines that selectively disrupt the pathways tumors cannot live without—while sparing normal cells—delivering more durable and meaningful benefit for patients.

Cells

Precision Beyond Genomics

Precision medicine often focuses on mutations. We go further:

  • Detect essential lineage dependencies that define tumor behavior.
  • Validate targets using advanced biological models.
  • Design molecules that selectively disrupt tumor lineage survival.

The result: Therapies designed to hit cancer where it cannot easily adapt.

Lineage Therapuetics:

Bringing percision medicine to more patients

Broad patient population,
but no precision

Empirical Medicine 1.0
Chemotherapy

Broad patient population, but no precision

Empirical Medicine 2.0
Immunotherapy

Broad patient population, but less precise

Broad patient population,
but less precise

Precise, but limited
patient population

Precision Medicine 1.0
Genomics-driven therapy

Precise, but limited patient population

Precision Medicine 2.0
Lineage-driven therapy

Precise and broad patient population

Precise and broad
patient population

Drug Discovery Approach

First-in-class target identification and drug discovery

Tree-diagram_v1

Lineage and Genomics

Lineage Surface Markers

DATA SCIENCE + WET LAB

Omics data mining:
DNA sequencing, RNAseq, methylation, proteomics

Cancer Cell Line Encyclopedia
(CCLE)

High-throughput Screeening
(HTS)

Deep-mecahnism driven assays

DepMap:
Cancer cell dependency mapping

AI data modeling

Disease specific animal models

AI-empowered medicinal chemistry

Drug Discovery Approach

First-in-class target identification and drug discovery

tree graphic
Root Cause

Lineage and Genomics

DATA SCIENCE + WET LAB

Omics data mining:
DNA sequencing, RNAseq, methylation, proteomics

Cancer Cell Line Encyclopedia
(CCLE)

DepMap:
Cancer cell dependency mapping

AI data modeling

tree graphic
End Effect

Lineage Surface Markers

DATA SCIENCE + WET LAB

High-throughput Screeening
(HTS)

Deep-mecahnism driven assays

Disease specific animal models

AI-empowered medicinal chemistry